Pharmacy Practice and Saudi Regulations Flashcards

A patient asks a pharmacist about the difference between their 'omeprazole' and a brand-name 'Losec.' What should the pharmacist explain?

Answer: Both contain the same active ingredient (omeprazole) and are bioequivalent — the generic is equivalent and less expensive

Generic medications contain the same active ingredient in the same dose/form and must demonstrate bioequivalence to the reference product (80–125% CI for AUC and Cmax). The SFDA approves generics that meet these standards. Generics are therapeutically equivalent and typically cost 20–80% less.

Under Saudi labor law and pharmacy regulations, what is a pharmacist's legal obligation when asked by an employer to perform an illegal dispensing practice?

Answer: Refuse the illegal practice and report it to the SCFHS or relevant regulatory authority — professional ethics and law override employer instructions

Pharmacists have an overriding professional and legal obligation to refuse instructions that violate pharmacy law or professional ethics, regardless of who gives the instruction. Reporting to regulatory authorities (SCFHS, SFDA, MOH) is both a professional and potentially legal obligation. Professional indemnity and licensure are at stake.

A pharmacist is preparing a sterile IV admixture in a hospital pharmacy clean room. Which ISO classification is required for the final product preparation zone?

Answer: ISO 5 (Class 100) — the critical zone where the final product is prepared within a laminar airflow workbench

USP (and equivalent Saudi/international standards) require: ISO 5 environment (laminar airflow workbench/BSC) for the final product preparation, ISO 7 buffer area/clean room, and ISO 8 anteroom. ISO 5 provides the lowest particle count critical environment needed to prevent contamination of sterile products.

A patient asks whether they can stop taking their antihypertensive medication since their blood pressure is now normal. What is the pharmacist's response?

Answer: Antihypertensive medications control but do not cure hypertension — stopping will cause BP to rise again; consult your physician before stopping

Antihypertensives treat (manage) hypertension but do not cure it. The normal blood pressure is the effect of the medication, not evidence of resolution. Stopping medication will cause BP to return to elevated levels in almost all patients. Any decision to reduce or stop therapy should be discussed with the prescribing physician.

A pharmacist is conducting a drug utilization review (DUR) for a patient. What is the purpose of a prospective DUR?

Answer: To screen prescriptions before dispensing for interactions, contraindications, duplications, and appropriateness — preventing problems before they occur

Prospective DUR occurs before dispensing — the pharmacist screens the new prescription against the patient's medication profile, checking for interactions, duplicate therapy, contraindications, inappropriate dosing, and allergies. It prevents drug therapy problems before they can harm the patient. Retrospective DUR analyzes patterns after the fact.

Saudi Arabia's Vision 2030 includes a healthcare transformation plan. Which pharmacy-related initiative is part of this transformation?

Answer: Expanding community pharmacy scope of practice to include medication therapy management, chronic disease monitoring, and vaccination services

Saudi Vision 2030 healthcare transformation includes enhancing primary care and expanding the role of pharmacists in community settings — medication therapy management (MTM), point-of-care testing, vaccination, chronic disease monitoring, and public health education. This shifts care from hospitals toward preventive, community-based models.